Olivier Mir, MD, PhD, MPH is a medical oncologist and clinical pharmacologist in Gustave Roussy Cancer Institute, University of Paris-Sud.
Dr. Mir trained as a medical oncologist and clinical pharmacologist at University Paris Descartes, and obtained the Silver medal (highest degree) from Paris Medical School in 2009.
Dr. Mir is currently member of Breast and Sarcoma Groups at Gustave Roussy Cancer Institute in Paris, and is an active member of the French Sarcoma Group (GSF-GETO), ASCO, ESMO, and EORTC Soft Tissue and Bone Sarcoma Group.
His main research interests are: sarcoma/GIST, anti-VEGF agents, early drug development, and geriatric oncology. He is also involved in translational research aspects related to precision medicine and pharmacokinetics notably in sarcoma/GIST. Dr. Mir has contributed to over 140 peer-reviewed medical publications.
Since 2014 he has been Associate Editor of ESMO Annals of Oncology Committee.